Breast Cancer Profiling Project, Drug Sensitivity phase II: Fixed-cell GR measures of 33 breast cell lines and PDX lines to 16 small molecule perturbagens from library plate II. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20354)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Mean Normalized Growth Rate Inhibition Value | Increased Fraction Dead |
|---|---|---|---|---|
| CAL-85-1 | GSK2334470 | 1.0 | 0.9344 | -0.00195 |
| CAL-85-1 | GSK2334470 | 1.0 | 0.8042 | -0.00200 |
| CAL-85-1 | GSK2334470 | 3.16227766017 | 0.8491 | -0.00036 |
| CAL-85-1 | GSK2334470 | 3.16227766017 | 0.8548 | -0.00784 |
| CAL-85-1 | GSK2334470 | 3.16227766017 | -0.1220 | 0.09265 |
| CAL-85-1 | GSK2334470 | 10.0 | 0.7636 | -0.00197 |
| CAL-85-1 | GSK2334470 | 10.0 | 0.8812 | -0.00887 |
| CAL-85-1 | GSK2334470 | 10.0 | 0.1906 | 0.01785 |
| CAL-85-1 | Ribociclib | 0.001 | 1.1887 | -0.00416 |
| CAL-85-1 | Ribociclib | 0.001 | 1.1102 | -0.00528 |
| CAL-85-1 | Ribociclib | 0.001 | 0.4193 | 0.00145 |
| CAL-85-1 | Ribociclib | 0.00316227766017 | 0.7779 | -0.00262 |
| CAL-85-1 | Ribociclib | 0.00316227766017 | 0.9201 | 0.00028 |
| CAL-85-1 | Ribociclib | 0.00316227766017 | 0.7917 | 0.00375 |
| CAL-85-1 | Ribociclib | 0.01 | 0.9321 | 0.00489 |
| CAL-85-1 | Ribociclib | 0.01 | 0.7933 | 0.00005 |
| CAL-85-1 | Ribociclib | 0.01 | 0.9703 | -0.00099 |
| CAL-85-1 | Ribociclib | 0.0316227766017 | 1.1953 | -0.00055 |
| CAL-85-1 | Ribociclib | 0.0316227766017 | 1.0535 | -0.00123 |
| CAL-85-1 | Ribociclib | 0.0316227766017 | 1.0413 | -0.00042 |
| CAL-85-1 | Ribociclib | 0.1 | 1.1367 | -0.00175 |
| CAL-85-1 | Ribociclib | 0.1 | 0.9065 | -0.00547 |
| CAL-85-1 | Ribociclib | 0.1 | 0.2225 | 0.04164 |
| CAL-85-1 | Ribociclib | 0.316227766017 | 0.8413 | -0.00091 |
| CAL-85-1 | Ribociclib | 0.316227766017 | 0.6352 | -0.00441 |